Chapter 8: Bipolar Disorders

The chapter details the diagnostic presentations and symptomatic presentations of manic and hypomanic states, including elevated mood, grandiosity, decreased need for sleep, racing thoughts, and impulsive behavior patterns that differentiate these conditions from unipolar depression. The neurobiology underlying bipolar disorder is explored through multiple biological systems, including dysregulation of monoamine neurotransmitters such as serotonin and norepinephrine, dysfunction within the hypothalamic-pituitary-adrenal axis, and neuroimaging findings showing structural and functional brain differences in regions involved in emotion regulation and impulse control. The chapter addresses the particular treatment challenges posed by rapid cycling patterns, where mood episodes shift frequently, and mixed states, where manic and depressive features occur simultaneously, both of which complicate therapeutic response and medication selection. Pharmacological approaches are thoroughly discussed, covering mood stabilizer medications including lithium and anticonvulsants, atypical antipsychotics used for acute mania and maintenance treatment, and the careful consideration required when prescribing antidepressants due to the risk of mood destabilization or episode acceleration. Psychotherapeutic interventions including cognitive-behavioral therapy, family-focused therapy, and interpersonal and social rhythm therapy are presented as essential adjuncts to medication management. The chapter also covers emerging treatment modalities such as electroconvulsive therapy for severe acute episodes and transcranial magnetic stimulation as a neurostimulation alternative. Throughout, the chapter emphasizes the importance of recognizing genetic predisposition, identifying comorbid conditions that frequently co-occur with bipolar disorders, and understanding when clinical presentation warrants referral for psychiatric medication management to optimize outcomes.